TELY.TO TELYRX HOLDINGS INC
$2.48▲ +3.33%
Healthcare
Other
Volume 919.5K
Avg Volume (10D) 3.0K
Key Metrics & Fundamentals
Market Cap
$65.94M
P/E Ratio
–
Div Yield
–%
52W Range
2.00 - 4.25
% vs 50 MA
-7.33%
% vs 200 MA
–%
RSI-14
43.3
MACD Histogram
-0.0200
Beta (1Y vs SPY)
0.78
Free Cash Flow
-$1.54M
Gross Rev
$19.39M
Gross Profit
$10.71M
EBITDA
-$1.88M
COGS
$8.69M
Operating Exp
$13.60M
Operating Income
-$2.89M
EBIT
-$2.89M
Pretax Income
-$4.68M
Net Income
-$4.68M
EPS (Diluted)
-0.19
Price & Volume History
Loading chart…
Recent News
TelyRx Announces Second Quarter 2026 Financial Results
TMX Newsfile · Aug 10, 2026 11:00 AM
TelyRx Launches New Brand and Digital Experience Inspired by Patient Feedback
CNW Group · Aug 4, 2026 11:30 AM
TelyRx to Host Second Quarter 2026 Financial Results Conference Call on Monday, August 10, 2026 at 8:30 am ET
TMX Newsfile · Jul 24, 2026 11:35 AM
TelyRx Holdings Expands Operations in Clearwater, Florida
MT Newswires · Jul 14, 2026 12:34 PM
TelyRx Expands Operations in Clearwater, Fla., Tripling Footprint to Meet Growing Demand for Digital Healthcare
PR Newswire · Jul 14, 2026 11:00 AM
Global Technology Virtual Investor Presentations Now Available for On-Demand Viewing
GlobeNewswire · Jul 10, 2026 12:35 PM
TelyRx Holdings Inc. Announces DTC Eligibility for U.S. Traded Shares
TMX Newsfile · Jul 10, 2026 11:00 AM
TelyRx to Present at the Global Technology Virtual Investor Conference July 9, 2026
TMX Newsfile · Jul 8, 2026 5:05 PM
TelyRx to Present at the Global Technology Virtual Investor Conference July 9th
GlobeNewswire · Jul 7, 2026 8:44 PM
Global Technology Virtual Investor Conference Agenda Announced
GlobeNewswire · Jul 6, 2026 1:16 PM
Financial Overview - Income Statement
Quarterly
Mar 2026
See TELY.TO's money flow as a full page
Social Sentiment
No Reddit posts found for TELY.TO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.